title: Major adverse cardiac events at long-term follow-up in patients treated with single versus multiple stents during single-vessel percutaneous coronary intervention.
abstract: BACKGROUND
  Although insertion of multiple stents into a single coronary vessel during single-vessel percutaneous coronary intervention (PCI) is common, there are no data on long-term occurrence of major adverse cardiac events (MACE) in patients treated with multiple stents versus a single stent.
  
  
  METHODS
  The incidence of MACE (death, myocardial infarction, or target vessel revascularization) during long-term follow-up was investigated in 634 patients who underwent single-vessel PCI. Of the 634 patients, 319 (50%) had a single stent, and 315 (50%) had multiple stents inserted. Stepwise Cox regression analyses were performed to identify significant independent prognostic factors for MACE.
  
  
  RESULTS
  At 47-month follow-up, MACE occurred in 61 of 319 patients (19%) who had a single stent versus in 57 of 315 patients (18%) who had multiple stents (P not significant). Significant independent predictors of MACE were use of vein grafts (hazard ratio = 1.94; 95% CI, 1.24-3.03; P = 0.0038) and use of drug-eluting stents (hazard ratio = 0.49; 95% CI, 0.34-0.72; P = 0.0002).
  
  
  CONCLUSIONS
  At long-term follow-up of single-vessel PCI, the incidence of MACE was similar in patients with multiple or single stents inserted even after controlling for the length of stents.
authors.affiliation: Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York 10595, USA.
authors.forename: Rishi
authors.initials: R
authors.lastname: Sukhija
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
authors.forename: Chandrasekar
authors.initials: C
authors.lastname: Palaniswamy
authors.forename: Tarunjit
authors.initials: T
authors.lastname: Singh
authors.forename: Chul
authors.initials: C
authors.lastname: Ahn
authors.forename: Kumar
authors.initials: K
authors.lastname: Kalapatapu
authors.forename: Bhavna
authors.initials: B
authors.lastname: Chaturvedi
authors.forename: Anthony L
authors.initials: AL
authors.lastname: Pucillo
authors.forename: Carmine
authors.initials: C
authors.lastname: Sorbera
authors.forename: Priyanka
authors.initials: P
authors.lastname: Kakar
authors.forename: Melvin B
authors.initials: MB
authors.lastname: Weiss
authors.forename: Vimal
authors.initials: V
authors.lastname: Mehta
authors.forename: Craig E
authors.initials: CE
authors.lastname: Monsen
mesh_terms: D000368:Aged; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D003327:Coronary Disease / Q000175:diagnosis / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D009204:Myocardial Revascularization / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods / Q000401:mortality; D012086:Reoperation; D012720:Severity of Illness Index; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome